Armata Pharmaceuticals (ARMP) Notes Payables (2016 - 2023)
Armata Pharmaceuticals' (ARMP) quarterly Notes Payables came in at $26.4 million in Q2 2023, down 18.64% quarter-over-quarter from $32.4 million in Q1 2023.
Armata Pharmaceuticals (ARMP) Notes Payables (2016 - 2023) Analysis & Trends
Armata Pharmaceuticals has disclosed Notes Payables across 3 years of filings, most recently posting $26.4 million for Q2 2023.
- Notes Payables for Q2 2023 came in at $26.4 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $26.4 million (changed N/A YoY), and the FY2016 annual result was $803000.0, changed N/A from the prior year.
- Notes Payables came in at $26.4 million for Q2 2023 at Armata Pharmaceuticals, down from $32.4 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $32.4 million in Q1 2023 to a low of $26.4 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 26.35 Mn |
| Mar 31, 2023 | 32.39 Mn |
| Sep 30, 2017 | 305,000.00 |
| Jun 30, 2017 | 606,000.00 |
| Mar 31, 2017 | 598,000.00 |
| Dec 31, 2016 | 803,000.00 |